11 completed, 1 recruiting, 1 withdrawn. 7 Phase 1, 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 6, Recruiting 1 |
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 3 | Completed 2, Withdrawn 1 |
Follow gallium nitrate: new trials by email Literature Review of gallium nitrate trials Research Report on gallium nitrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) Gallium nitrate - Nontuberculous Mycobacterium Infection | Phase 1 | Recruiting | Chris Goss | 40 | 2021-06-17 | 2025-10-01 |
| Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro Gan & Lee Insulin Lispro Injection, Humalog - Diabetes Mellitus, Type 1 | Phase 3 | Withdrawn | Gan and Lee Pharmaceuticals, USA | 2019-12-04 | 2020-02-05 | |
| PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males Gan & Lee Insulin Aspart - Diabetes Mellitus, Type 1 | Phase 1 | Completed | Gan and Lee Pharmaceuticals, USA | 36 | 2019-08-27 | 2020-02-13 |
| PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males Gan & Lee Insulin Lispro Injection - Diabetes Mellitus | Phase 1 | Completed | Gan and Lee Pharmaceuticals, USA | 36 | 2019-04-23 | 2020-02-13 |
| PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellitus Patients Gan & Lee Insulin Glargine Injection - Diabetes Mellitus, Type 1 | Phase 1 | Completed | Gan and Lee Pharmaceuticals, USA | 114 | 2018-07-10 | 2020-01-22 |
| Gan & Lee Insulin Glargine Target Type (2) Evaluating Research Gan & Lee Insulin Glargine Injection, Lantus® - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Gan and Lee Pharmaceuticals, USA | 567 | 2017-10-31 | 2022-04-01 |
| Gan & Lee Insulin Glargine Target Type (1) Evaluating Research Gan & Lee Insulin Glargine Injection, Lantus® - Diabetes Mellitus, Type 1 | Phase 3 | Completed | Gan and Lee Pharmaceuticals, USA | 576 | 2017-10-31 | 2024-05-14 |
| A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study) Gallium nitrate, Normal Saline - Cystic Fibrosis | Phase 2 | Completed | University of Washington | 119 | 2016-03-01 | 2019-03-21 |
| PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes Gan & Lee insulin glargine followed by Lantus, Lantus followed by Gan & Lee insulin glargine - Diabetes Mellitus, Type 1 | Phase 1 | Completed | Gan and Lee Pharmaceuticals, USA | 41 | 2015-12-01 | 2017-01-26 |
| A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients 100 mg/m2 dose, 200 mg/m2 dose - Cystic Fibrosis | Phase 1 | Completed | University of Washington | 20 | 2010-04-01 | 2022-11-29 |
| Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma gallium nitrate - Non-Hodgkin's Lymphoma, Relapsed Lymphoma | Phase 2 | Completed | Genta Incorporated | 40 | 2002-06-01 | 2006-02-08 |
| Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors gallium nitrate - Brain and Central Nervous System Tumors, Lymphoma | Phase 1 | Completed | Medical College of Wisconsin | 3 | 1995-02-01 | 2013-07-18 |
| Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma cytarabine, gallium nitrate, leucovorin calcium - Lymphoma | Phase 2 | Completed | Roswell Park Cancer Institute | 35 | 1994-08-01 | 2015-10-06 |
Diabetes Mellitus (6) · Insulin Resistance (6) · Diabetes Mellitus, Type 1 (5) · Cystic Fibrosis (3) · Lymphoma (3) · Burkitt Lymphoma (1) · Central Nervous System Neoplasms (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Diabetes Mellitus, Type 2 (1) · Lymphoma, Non-Hodgkin (1) · Mycobacterium Infections, Nontuberculous (1) · Mycobacterium avium-intracellulare Infection (1) · Neuroblastoma (1) · Pseudomonas Infections (1) · Recurrence (1)
Gan and Lee Pharmaceuticals, USA (7) · University of Washington (2) · Chris Goss (1) · Genta Incorporated (1) · Medical College of Wisconsin (1) · Roswell Park Cancer Institute (1)
United States (10) · Germany (5) · Czechia (2) · Hungary (2) · Poland (2) · Spain (2)
Jia Lu, PhD (4) · Christopher H Goss, MD (1) · Christopher H Goss, MD, MSc (1) · Christopher H. Goss, MD, MSc (1) · Elena A. Christofides, MD, FACE (1) · Elena A. Christofides, MD,FACE (1) · Harry T. Whelan, MD (1) · Jia Lu, MD, PhD (1) · Lawrence P. Leichman, MD (1) · Marcus Hompesch, MD (1) · Matthew E Barton, PhD (1)